DRG Financing System Presents Uncertainties For Healthcare Sector
DRG Financing System Presents Uncertainties For Healthcare Sector
RHB Research emphasised that DRG is not a price-capping mechanism but a discipline-focused approach aimed at improving efficiency and medical outcomes. The research house believes that the system could benefit both hospitals, by optimising resources and patients, through better care delivery.RHB Investment Bank Bhd (RHB Research) has maintained its OVERWEIGHT call on the healthcare sector, identifying IHH Healthcare as its top pick due to its diversified asset base, which positions it well to navigate regulatory uncertainties.
RhB Investment Bank Bhd（RhB Research）维持了对医疗保健行业的增持看涨期权，将IHH Healthcare确定为其首选，因为其多元化的资产基础使其能够很好地应对监管的不确定性。
The research house highlighted that the recent introduction of a diagnosis-related group (DRG) financing system in Malaysia is expected to benefit hospitals and patients in the long term by streamlining procedures and enhancing resource allocation. However, RHB Research noted that the system also introduces short-term uncertainties regarding its implementation extent.
该研究机构强调，马来西亚最近推出的诊断相关团体（DRG）融资体系预计将通过简化程序和加强资源分配，使医院和患者长期受益。但是，RhB Research指出，该系统的实施程度也带来了短期的不确定性。
The research house mentioned that while the DRG system moves away from the traditional fee-for-service model by specifying a fixed payment amount based on the complexity of a case, the transition to the DRG system requires extensive study and stakeholder engagement due to the varying complexities and costs of medical procedures.
该研究机构提到，尽管DRG系统通过根据病例的复杂性指定固定付款金额来摆脱传统的收费服务模式，但由于医疗程序的复杂性和成本各不相同，向DRG系统的过渡需要广泛的研究和利益相关者的参与。
RHB Research emphasised that DRG is not a price-capping mechanism but a discipline-focused approach aimed at improving efficiency and medical outcomes. The research house believes that the system could benefit both hospitals, by optimising resources and patients, through better care delivery.
RhB Research强调，DRG不是一种价格上限机制，而是一种以学科为重点的方法，旨在提高效率和医疗结果。该研究机构认为，该系统可以通过优化资源和通过更好的医疗服务使两家医院受益，从而使两家医院受益。
It also highlighted recent sell-offs in the healthcare sector, attributing them to uncertainties around the DRG implementation. However, RHB Research viewed this as an opportunity for investors to capitalise on attractive entry points, especially for those with a long-term perspective on the structural changes in the industry.
它还强调了医疗保健行业最近的抛售，将其归因于DRG实施的不确定性。但是，RhB Research认为这是投资者利用有吸引力的切入点的机会，特别是对于那些从长远角度看待行业结构性变化的投资者而言。
For investors concerned about potential unfavourable outcomes from the DRG system, RHB Research pointed to Sunway Group as a viable alternative. With diversified exposure across sectors such as data centre construction, property development, and hospitality, Sunway is seen as capable of mitigating any negative impact on its healthcare unit. The healthcare division contributed 14.5% of the group's profit before tax for the first nine months of 2024 and 34% of RHB Research's estimated restated net asset value.
对于担心DRG体系潜在不利结果的投资者，RhB Research指出，信威集团是一个可行的替代方案。凭借数据中心建设、房地产开发和酒店业等领域的多元化投资机会，Sunway被认为能够减轻其医疗保健部门的任何负面影响。该医疗保健部门在2024年前九个月贡献了该集团税前利润的14.5％，占RhB Research估计的重报净资产价值的34％。
译文内容由第三方软件翻译。
